Ji would be better off not PRing anything. Whenever he does it reminds people that he has NEVER gotten one drug approved.
10 out of 10 is great - especially for those specific 10 people - but another randomized, multiply center, blah, blah study that will be done when covid is mostly over does nothing for the value of this company.